UK: Maersk Drilling secures one-well UK contract for Maersk Resolve
13 Jan 2021
Spirit Energy for the harsh-environment jack-up rig
Maersk Resolve to drill one development well at
Grove North East
in the UK North Sea. The contract is expected to commence in March 2021, with an estimated duration of 131 days. The firm contract value is approx. USD 11.3m, including additional services, mobilisation and demobilisation. The contract includes an option to add plugging and abandonment of one well.
Maersk Drilling secures one-well UK contract for Maersk Resolve
“We’re excited to be able to build on our relationship with Spirit Energy with our first UK well for the customer, for whom we previously completed a highly successful subsea development campaign in Norway. We will surely be able to continue our close collaboration and mutual focus on operational excellence, and in addition the campaign at Grove will benefit from Maersk Resolve’s experience with safely and efficiently
Uruguay: PGS enters exploration data rejuvenation agreement with ANCAP
13 Jan 2021
Uruguay s state oil company ANCAP
to reprocess over 11,000 km of existing 2D lines of various vintages, applying the latest seismic imaging techniques.
This rejuvenation will provide new, reprocessed 2D seismic that will tie with PGS’ existing 15,600 sq km MultiClient 3D survey, covering the Punta del Este and Pelotas basins.
The Punta del Este basin develops in the western part of the offshore of Uruguay near the border with Argentina. It was formed by a failed rift structure in the Late Jurassic, producing a northwest-southeast (NW–SE) fault trend.
The Pelotas basin develops in the eastern part of the offshore of Uruguay and extends through several kilometers into offshore Brazil. It was formed during the Early Cretaceous with the subsequent opening of the Atlantic Ocean, forming a NE–SW fault trend.
/PRNewswire/ There was a meeting of the minds when National Health Foundation (NHF) signed a contract to bring Everytable s food to its guests experiencing.
AuraVax Therapeutics Enters into Exclusive License Agreement with Massachusetts General Hospital for Intranasal Vaccine and Therapeutics Platform Transaction bolsters development of AuraVax s lead COVID-19 intranasal vaccine and strengthens platform for therapeutic development targeting a range of viral infections
News provided by
Share this article
Share this article
HOUSTON, Jan. 13, 2021 /PRNewswire/ AuraVax Therapeutics Inc. (www.auravax.com), a biotech company developing novel intranasal vaccines and therapies to help patients defeat debilitating diseases, including COVID-19, today announced it has entered into an exclusive license agreement with Massachusetts General Hospital (MGH) covering certain intellectual property and technology rights regarding compositions and discoveries of liposomal STING agonists by Mei X. Wu, PhD, of the Wellman Center for Photomedicine at MGH. Research related to this technology was published in
The government will sell up to 10 per cent of stake held in Steel Authority of India through an offer for sale, in a move that’s expected to fetch Rs 2,600 crore to the exchequer in divestment receipts. The government is selling 206.5 million shares or 5 per cent in the one of the largest steel-making companies with a floor price of Rs 64 a share. It has also kept the option to sell another 5 per cent if the issue is oversubscribed. The government’s stake post the sale will come down from 75 per cent to 65 per cent if the greenshoe option is exercised.